We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics

By LabMedica International staff writers
Posted on 03 Jan 2023

Since the year 2003, Tianlong Science and Technology (Shaanxi, China) has witnessed several health crises globally and has also contributed to China’s power to prevent and control major epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever.

Tianlong is an innovative high-tech company specializing in molecular diagnostic products. Since being founded in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. The company has a wide range of products from devices to reagents, including nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents.


Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)
Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)

With NMPA, CE, and FDA marks, Tianlong’s products are exported to more than 100 countries and regions worldwide, and have greatly helped in the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever. Tianlong continues to excel in R&D and bringing technology to life to make people's lives healthier and happier.

Related Links:
Tianlong Science and Technology


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Electrolyte Analyzer
CBS-4000 (CBS-400)
Thyroid Test
Anti-Thyroid EIA Test

Latest Industry News

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
02 Jan 2023  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
02 Jan 2023  |   Industry

Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition
02 Jan 2023  |   Industry



PURITAN MEDICAL